Website Design Services for Biopharmas
A biopharma website answers to more masters than any site in industry, medical accuracy, legal review, investor scrutiny, HCP expectations, patient accessibility. We design sites that satisfy all of them and still move fast enough for a company approaching launch.
Biopharma Website Challenges We Solve
The website problems we most often fix for biopharma companies:
Our Biopharma Website Design Services
MLR-ready, launch-scalable, actually updatable.
Review-velocity architecture
Modular content structured so approved components update in days, the build designed around your MLR process, not despite it.
Science & pipeline clarity
The platform and programs explained at layered depth, rigorous for the field, clear for capital, current by system.
Audience pathing
HCPs, investors, patients, and candidates each routed cleanly, one clear company, four compliant experiences.
Evidence assembly
Publications, presentations, and data organized as a findable body of proof, the diligence and medical-affairs layer, pre-built.
Launch-ready platform
Architecture that scales to the disease-state and brand properties launch will require, decided now, not rebuilt later.
WordPress build
Fast, secure, editable by your communications team within the review workflow, hosted on Kinsta.
Our Biopharma Website Design Process
Run with your reviewers, not around them.
Discovery
We learn the science, the corporate calendar, the audiences, and the review process, with medical, legal, and regulatory involved from day one.
Content & structure
Platform, pipeline, and audience content written in reviewable modules, the compliance structured in, not bolted on.
Design
Precise, current, credible to every audience, judged against the companies your partners and candidates also evaluate.
Build & migrate
WordPress build, update workflows, audience routing, and redirect mapping so existing authority survives.
Launch & optimize
Post-launch we track each audience’s paths, and the update velocity, because that metric decides whether the site stays true.
Biopharma Website Design FAQs
How does the build actually speed MLR review?
Modularity, content structured as discrete, reviewable components means changes route only what changed, and approved modules redeploy without re-review. The bottleneck is usually structure, not reviewers. The build fixes the structure.
When should launch properties get planned?
Now, the disease-state and eventual brand sites should be architectural decisions made before they’re urgent, so authority allocates carefully and nothing gets rebuilt under launch pressure.
How do we serve investors without tripping disclosure concerns?
Within your disclosure posture, investor pathing built with your counsel’s review, answering diligence questions from the approved record. The architecture separates registers. Your process governs content.
How long does a biopharma site take?
Typically sixteen to twenty weeks, review cycles are the honest pacing item, and we schedule with them, which is itself the first demonstration of the velocity discipline.